ArticleCellular and molecular life sciences : CMLS2026
Maternal MLH3 dysfunction drives unexplained recurrent pregnancy loss via impaired oocyte maturation and defective decidualization.
Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Unexplained recurrent pregnancy loss (URPL) represents a prevalent obstetric complication and remains a challenging condition with poorly understood genetic etiology. Through whole-exome sequencing of 94 URPL patients, we identified enriched MLH3 gene mutations in five individuals (p.G1302Efs21/p.G752E, p.V741F/p.S845G, p.V1220M/p.L1339F, p.T942I/p.G1163D, p.I988M/p.A1426V), with a 5.32% mutation frequency in this cohort which significantly exceeded the general population prevalence (0-0.011%), suggesting MLH3's potential pathogenicity in URPL. Functional characterization using a Trim-Away-mediated Mlh3 depletion model in mouse germinal vesicle (GV)-stage oocytes revealed that Mlh3 loss disrupts spindle assembly, mislocalizes the spindle assembly checkpoint kinase BubR1, and induces focal chromosomal imbalances in early embryos. These defects lead to impaired blastocyst development and a high rate (63.89%) of post-implantation pregnancy loss after embryo transfer, recapitulating human URPL in vivo. Concurrently, MLH3 knockdown in human endometrial stromal cells impaired decidualization, disrupted morphological transformation, and altered proliferation-apoptosis homeostasis, indicating defective endometrial receptivity. Together, these findings establish maternal MLH3 as a dual-function gene essential for both oocyte quality and endometrial receptivity, providing a novel mechanistic basis for its role in URPL pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.